Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IL1R1 antisense RNA 1 (IL1R1-AS1) is a long noncoding RNA gene transcribed in the antisense orientation to the interleukin-1 receptor type 1 (IL1R1) gene. While lncRNAs of the antisense type often regulate the expression of their sense (protein-coding) counterparts, such as by altering chromatin structure, affecting transcription, or forming RNA duplexes to influence mRNA stability, there is no direct evidence for a unique protein product or direct therapeutic targeting of IL1R1-AS1. Like other antisense lncRNAs, IL1R1-AS1 could play a role in regulating inflammation and immune responses by modulating the expression of the IL1R1 receptor or related genes. However, its specific biological functions, disease relevance, and potential as a clinical biomarker or therapeutic target are currently not well characterized in the scientific literature. No search results yielded primary research directly on IL1R1-AS1; this answer leverages standard knowledge about antisense lncRNAs and recognized genomic annotations. If more detailed functional data or disease links arise, these fields can be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IL1R1 antisense RNA 1 (IL1R1-AS1).